dermatofibrosarcoma protuberans rare locally aggressive malignant cutaneous softtissue sarcoma dfsp develops connective tissue cells middle layer skin estimates overall occurrence dfsp united states cases per million persons per united states dfsp accounts percent softtissue percent cutaneous softtissue sarcomas surveillance epidemiology end results seer tumor registry dfsp second kaposi sarcoma dermatofibrosarcoma protuberans begins minor firm area skin commonly cm diameter resemble bruise birthmark pimple slowgrowing tumor usually found torso occur anywhere dfsps lowgrade sarcomas mixed containing highgrade sarcomatous component dfspfs therefore considered intermediategrade sarcomas dfsps rarely lead metastasis fewer metastasize dfsps recur locally dfsps often arise patients thirties may due diagnostic delay commonly located chest shoulders following site distribution dfps observed surveillance epidemiology end results seer database world health organization classified fibro sarcomatous dfsp dfspfs variant also termed dermatofibrosarcoma protuberans fibro sarcomatous dermatofibrosarcoma protuberans specific form intermediate rarely metastasizing fibroblastic myofibroblastic tumors variants disorder specific form intermediate locally aggressive fibroblastic myofibroblastic bednar pigmented dfsp distinguished dispersal melaninrich dendritic cells skin represents dfsp occurring people rich melanin pigments bednar characterized dermal spindle cell proliferation like dfsp distinguished additional presence melanocytic dendritic cells occurs rate dfsp fairer skin considered chances myxoid dfsp areas myxoid degeneration giant cell contains giant cells also known juvenile giant cell fibroblastomas skin softtissue tumors usually arise childhood sometimes seen association dermatofibrosarcoma protuberans dfsp hybrid lesions may transform recur atrophic dfsp resemble benign lesions morphea idiopathic atrophoderma atrophic scar anetoderma lipoatrophy behaves like classic dfsp commonly favours young middleaged adults slow infiltrative growth high rate local recurrence completely sclerosing dfsp variant cellularity low tumor consists uniform bundles collagen interspersed typical dfsp granular cell variant rare type spindle cells mingled richly granular cells granules lysosomal prominent fibrosarcomatous dfsp rare variant dfsp involving greater aggression high rates local occurrences higher metastatic dfspfs considered intermediategrade although rarely metastasize fewer percent cases dfsp tumors chromosomal translocation translocation fuses collagen gene plateletderived growth factor pdgf gene fibroblast cell origin tumor expresses fusion gene belief codes collagen however resulting fusion protein processed mature plateletderived growth factor potent growth factor fibroblasts contain receptor growth factor thus cell thinks producing structural protein creates selfstimulatory growth signal cell divides rapidly tumor forms tissue often positive dfsp malignant tumor diagnosed biopsy portion tumor removed examination order ensure enough tissue removed make accurate diagnosis initial biopsy suspected dfsp usually done core needle surgical clinical palpation entirely reliable ascertaining depth dfsp infiltration magnetic resonance imaging mri sensitive addressing depth invasion types dfsp particularly large recurring though mri less accurate identifying infiltration head neck tumors due rarity initial presentation flat plaque skin hardening slowgrowing nature dfsp may months years without protuberance bump dissonance name neoplasm clinical presentations may cause majority patients experience diagnostic delay research study found patients range less year years diagnosis median four years patients noticing symptom currently majority patients receive misdiagnosis health care providers frequent prebiopsy clinical suspicion included cyst lipoma scar suggested alternative term dfsp dermatofibrosarcoma often suggested dfsps may enlarge rapidly pregnancy immunohistochemical stains protein factor xiiia estrogen progesterone receptors performed biopsy specimens tumors showed expression progesterone receptor many stromal neoplasms dfsps appear express low levels hormone receptors may one factor accounts accelerated growth treatment primarily surgical chemotherapy radiation therapy used clear resection margins type surgical treatment chosen dependent location dfsp occurrence possible size mohs micrographic surgery mms high cure rate lowers recurrence reduction negative resection margins achieved wide local excision wle gold standard treating dfsp currently reevaluation presently united states wle may suggested recurrence mms larger resection margins suggested wle mms recurrence rate wle lower recurrence rate related wider dfsp characteristic features capacity invade surrounding tissues considerable distance central focus tumor tentaclelike fashion fact coupled diagnostic delay may lead inadequate initial resection inadequate initial treatment results larger deeper recurrent lesions managed appropriate wide dfsp radioresponsive tumor radiation therapy rt used first choice treatment conservative resection mms wle attempted first clear margins achieved rt chemotherapy dfsp previously regarded nonresponsive standard us fda approved imatinib mesylate treatment true medicinal drugs name ending ib imatinib small molecular pathway inhibitor imatinib inhibits tyrosine kinase may able induce tumor regression patients recurrent dfsp unresectable dfsp metastatic clinical evidence imatinib inhibits pdgfreceptors may effective tumors positive translocation suggested imatinib may treatment challenging locally advanced disease rare metastatic cases approved use adult patients unresectable recurrent andor metastatic dermatofibrosarcoma protuberans distant hematogenous metastases extremely metastases regional lymph nodes rarer likely patients multiple local recurrences inadequate surgical repeatedly recurring tumors increased risk transformation malignant form dfspfs lungs frequently affected metastases soft tissues reported dfsp extensively studied due rarity low mortality majority studies small size case studies metaanalysis extensive research study date perspectives patients dermatofibrosarcoma protuberans diagnostic delays surgical outcomes lead researcher jerad gardner spoke ted talk february r w taylor first identified dfsp keloid sarcoma later ferdinandjean darier ferrand identified progressive recurrent dermatofibroma e coined term dermatofibrosarcoma protuberans bednar tumor first described bednar following medical codes subcutaneous tissue infiltration ie honeycomb growth pattern monotonous plexiform structure tumour dfsp formed fibroblastic histiocytic elements hemosiderin deposits beneath tumour immunostain positive httpsenwikipediaorgwikidermatofibrosarcomaprotuberans